Want to inform investors similar to Hubei Biocause Pharmaceutical about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Hubei Biocause Pharmaceutical Acquisitions
1 Acquisition
Hubei Biocause Pharmaceutical acquired 1 company. Their latest acquisition was Guohua Life Insurance on January 22, 2015.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
1/22/2015 | Corporate Majority | 1 |
Date | 1/22/2015 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Corporate Majority |
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
Request a demo